Despite the critical role that TGF-␤ plays in renal fibrosis, transgenic mice that overexpress human latent TGF-␤1 in the skin exhibit normal renal histology and function even though circulating levels of latent TGF-␤1 are an order of magnitude higher than wild-type animals. In fact, latent TGF-␤1 seems to protect against renal inflammation in a model of ureteral obstruction. It is unknown, however, whether latent TGF-␤1 also has this effect in immunologically mediated forms of renal disease such as anti-GBM crescentic glomerulonephritis. We induced anti-GBM disease in wild-type and transgenic mice overexpressing latent TGF-␤1 in keratinocytes. After 14 days, wild-type mice developed progressive crescentic glomerulonephritis with severe renal inflammation and fibrosis. In transgenic mice, proteinuria was reduced by 50%, renal function was preserved, and the formation of glomerular crescents was suppressed by 70%. In addition, transgenic animals had reduced renal inflammation, evidenced by a 70% decrease in the accumulation of T cells and macrophages, and reduced expression of renal IL-1␤, TNF␣, and MCP-1 by 70 to 80%. Progressive renal fibrosis was also prevented in the transgenic mice, and these protective effects were associated with elevated levels of latent, but not active, TGF-␤1 in plasma and renal tissue. Renal Smad7 was up-regulated and both NF-B and TGF-␤/Smad2/3 activation were suppressed. In conclusion, mice overexpressing latent TGF-␤1 in the skin were protected against anti-GBM crescentic glomerulonephritis, possibly via Smad 7-mediated inhibition of NF-B-dependent renal inflammation and TGF-␤/Smad2/3-dependent fibrosis.
TGF-␤1 exhibits a broad spectrum of biological functions in inflammation, immune response, and tissue repair/ fibrosis. 1,2 Although TGF-␤1 play a critical role in renal fibrosis, 3 little attention has been paid to the potential role of this cytokine in inflammatory and immune-mediated kidney diseases. TGF-␤ is an anti-inflammatory cytokine and functions in both autocrine and paracrine manners to regulate cell proliferation, apoptosis, chemotaxis, immunity, and inflammatory response. 1, 2 This is illustrated by the finding that mice with targeted disruption of TGF-␤1 develop a wasting syndrome associated with multifocal inflammation at about 3 wk after birth. 4 In addition, systemic administration or overexpression of TGF-␤ produces an inhibitory effect on erosive arthritis, 5 autoimmune encephalomyelitis, 6 insulitis in nonobese diabetic mice, 7 and systemic lupus erythematosus in the MRL/lpr/lpr mice. 8 These findings provide strong evidence for the anti-inflammatory properties of TGF-␤ in the disease conditions.
It has been shown that mice with overexpression of active TGF-␤1 in the liver develop severe renal damage with progressive renal fibrosis. 9 In contrast, we have recently found that TGF-␤1 Tg mice overex-pressing a human Wt-TGF-␤1 in the skin exhibit a normal renal histology and function without detectable kidney abnormalities, despite a ten-fold increase in circulating levels of latent TGF-␤1. 10 Moreover, we also found that mice with elevated levels of a latent form of TGF-␤1 in plasma and renal tissues are able to prevent renal inflammation in a mouse model of obstructive kidney. 10 These contradictory findings suggest a complex role of TGF-␤1 in renal pathophysiological conditions.
Although it is known that mice overexpressing latent TGF-␤1 can prevent renal inflammation in a model of obstructive kidney induced by ureteral ligation, 10 it remains unclear whether latent TGF-␤1 is able to protect against renal injury under the immunological condition. To address this question, we examined the functional role of TGF-␤1 in an immunologically induced kidney disease induced in TGF-␤1 Tg mice by administrating the sheep anti-mouse glomerular basement membrane (GBM) antibody. In this model, a severe and rapidly progressive crescentic GN was developed and the protective role of TGF-␤1 in immune-mediated kidney disease was investigated.
RESULTS

Circulating and Renal Tissue TGF-␤1 in Normal and
Diseased Mice with Anti-GBM Crescentic GN As reported previously, 10 normal Tg mice showed a significant higher level of total TGF-␤1 in plasma, but not in renal tissues ( Figure 1, A and D) . Of them, more than 50% were a latent form of TGF-␤ ( Figure 1B ). In the disease conditions, levels of plasma and renal latent TGF-␤1 remained higher in Tg mice (Ͼ70%), but lower in Wt mice (Ͻ30%, Figure 1 , B and E). Interestingly, active TGF-␤1 in plasma was higher in normal Tg mice, accounting for Ͻ15% of total plasma TGF-␤1, however, this was not altered during anti-GBM GN. In contrast, levels of active TGF-␤1 were significantly increased in the diseased Wt mice compared with normal ( Figure 1C ), accounting for more than 30% of total plasma TGF-␤1 in Wt mice. Importantly, active TGF-␤1 was significantly increased in the diseased kidney in Wt mice (a two-fold increase), but it remained normal in Tg mice ( Figure 1F ).
Mice Overexpressing TGF-␤ 1 are Protected against Crescentic GN Histologically, both normal Wt and Tg mice exhibited a normal renal histology ( Figure 2, A and B) . However, Wt mice developed severe crescentic GN with progressive renal inflammation and fibrosis ( Figure 2 , C and E). This was accompanied by a marked increase in proteinuria ( Figure 2F ), a rise in serum creatinine, and a fall in creatinine clearance ( Figure 2 , G and H). All of these pathologic changes were substantially inhibited in Tg mice (Figure 2 , D through H), resulting in 60% to 70% reduction of glomerular crescents and total urinary protein excretion, and prevention of a rise in serum creatinine and a fall of creatinine clearance. This was associated with a marked inhibition of cell proliferation as shown in Figure 3 . Indeed, massive PCNAϩ proliferating cells in glomerular crescents and in areas of tubulointerstitial damage were largely reduced in Tg mice compared with Wt mice (Figure 3 , C through F).
Complement-Mediated Renal Injury is Inhibited in TGF-␤1 Tg Mice with Anti-GBM Crescentic GN
Immunofluorescence showed that there was no difference in immune deposition of the sheep anti-mouse GBM IgG (Figure 4 , A, D, and G) and mouse IgG (Figure 4 , B, E, and H) along the GBM in both Wt and Tg mice. However, strong complement C3 deposition noted in Wt mice was significantly inhibited in Tg mice ( Figure 4 , C, F, and I). Circulating levels of mouse immunoglobulins were comparable in both normal Wt and Tg mice, but significantly increased in the diseased Tg mice (Figure 4 , J and K).
Cell-Mediated Renal Injury in Anti-GBM Crescentic GN is Inhibited in TGF-␤ Tg Mice T cell and macrophage infiltration is a typical feature of anti-GBM crescentic GN. As shown in Figure 5 and Figure 6 , although no difference in numbers of T cells and macrophages was found in the kidney in normal Wt and Tg mice ( Figure 5A and Figure 6A ), Wt mice developed a dense T cell and macro- phage infiltration within the diseased kidney, contributing significantly to glomerular crescentic formation and severe tubulointerstitial damage ( Figure 5C and Figure 6C ), which was substantially inhibited in Tg mice as shown in Figure 5D and Figure 6D . Quantitative analysis confirmed these observations ( Figure 5 , E and F and Figure 6 , E and F), respectively. It has been well accepted that pro-inflammatory cytokines including IL-1 and TNF␣ as well as chemokines such as MCP-1 play an important role in the pathogenesis of anti-GBM GN. We next examined the expression of IL1␤, TNF␣, and MCP-1 by real-time PCR. As shown in Figure 7 (A through C), real-time PCR demonstrated that Wt mice exhibited a significant increase in the mRNA level of IL-1␤, TNF␣, and MCP-1 in the diseased kidney, which was prevented in the TGF-␤1 Tg mice.
Renal Fibrosis in Wt Mice with Anti-GBM GN is Prevented in TGF-␤ Tg Mice TGF-␤ is a key fibrotic growth factor in renal fibrosis. This is further demonstrated by the finding that mice overex- and Tg (D) mice; (E, F) semiquantitative analysis of PCNAϩ cells within the kidney. Note that massive cell proliferation is found in the diseased kidney in Wt mice (C), contributing significantly to severe glomerular crescentic formation (*), which is prevented in Tg mice (D). Each bar represents the mean Ϯ SEM for a group of eight mice with anti-GBM GN and six normal mice. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 compared with normal mice; ###P Ͻ 0.001 when compared with the Wt mice. Magnification, ϫ200.
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pressing an active human TGF-␤1 develop severe liver and kidney fibrosis. 9 We next examined whether mice overexpressing a latent TGF-␤1 develop renal fibrosis. Unexpectedly, real-time PCR showed that Tg mice with higher levels of latent TGF-␤1 were protected from renal fibrosis as evident by a significant inhibition of increased renal collagen I, III, and ␣-SMA mRNA in Wt mice ( As shown in Figure 9 , analyses by real-time PCR and Western blot revealed that, compared with wild-type mice, a marked increase in renal Smad7 mRNA and protein was found in both normal and diseased kidney in TGF-␤1 Tg mice. This was associated with a marked inhibition of NF.B/p65, but not p50 (data not shown), activation ( Figure 10A 
DISCUSSION
We report here that mice overexpressing a latent form of TGF-␤1 on the skin have a protective role in the development of crescentic GN. This was supported by the findings that Tg mice were able to prevent glomerular crescent formation, a rise in proteinuria and plasma creatinine, a fall of creatinine clearance, and the development of renal inflammation including T cell and macrophage accumulation, cell proliferation, expression of IL-1␤, TNF␣, and MCP-1, and complement C3 deposition. Unexpectedly, we also found that renal fibrosis was prevented in Tg mice as evident by suppression of collagen I, III, ␣-SMA mRNA expression and their matrix protein accumulation. Further study revealed that upregulation of renal Smad7, thereby preventing NF.B/p65 and TGF-␤/Smad2/3 from activation, may be a central mechanism by which TGF-␤1 Tg mice are protected against renal inflammation and fibrosis in anti-GBM crescentic GN.
TGF-␤1 is a pleiotropic cytokine with diverse roles in inflammation and fibrosis. 1,2 TGF-␤1 is produced and secreted as a latent complex, consisting of mature dimeric TGF-␤1, a latency-associated peptide (LAP), and a latent TGF-␤ binding protein (LTBP). LAP binds to the N-terminal of TGF-␤ to prevent it from binding to its receptors, whereas LTBP-1 binds the LAP-TGF-␤ complex to prevent TGF-␤ from interacting with local matrix proteins. TGF-␤ must be released from LAP BASIC RESEARCH www.jasn.org to become activated by factors including plasmin, thrombospondin-1, reactive oxygen species, and acid. 11, 12 There were several mechanisms whereby latent TGF-␤1 may exert its anti-inflammatory properties in anti-GBM GN. First, blockade of IL-1, TNF-␣, and MCP-1 and inhibition of T cell and macrophage infiltration could be the mechanism by which elevated levels of latent TGF-␤1 in plasma and renal tissues in Tg mice inhibited anti-GBM crescentic GN. This was consistent with previous findings that TGF-␤ acts as an endogenous defender against IL-1␤, TNF␣, and MCP-1 production. [13] [14] [15] [16] [17] Second, inhibition of complement C3 deposition within the inflamed kidney indicated that TGF-␤1 may have a protective role in complement-mediated renal injury in anti-GBM GN. This may be associated with inhibition of complement C3 synthesis by TGF-␤ in response to inflammatory cytokines 18, 19 and may be also associated with suppression of complement activation locally by blocking renal inflammation in response to high levels of latent TGF-␤1. Third, inhibition of cell proliferation could be another mechanism leading to suppression of crescentic GN in TGF-␤1 Tg mice, because upregulation of Smad7 is able to block NF.B-dependent cell proliferation and induce apoptosis. 20, 21 Finally, overexpression of latent TGF-␤1 may produce an inhibitory effect specifically on T cell proliferation, activation, and Th1 differentiation, thereby blocking T cell-mediated crescentic GN. Administration or overexpression of TGF-␤1 have been shown to suppress autoimmune diseases including arthritis, 5 autoimmune encephalomyelitis, 6 insulitis, 7 and systemic lupus erythematosus. 8 T cells engineered to specifically produce latent TGF-␤1 reverse allergen-induced airway inflammation and suppress colitis, 22, 23 suggesting that latent TGF-␤1 derived from immune effector cells plays a protective role in autoimmune diseases. In the studies presented here, we provided new information that latent TGF-␤1 produced by skin keratinocytes also plays a protective role in immune-mediated crescentic GN via a paracrine manner. Indeed, TGF-␤ signaling is critical in maintaining peripheral T regulatory cells and inhibiting T cell activation and Th1 differentiation. 24, 25 Mice with T cell specific deletion of TGF-␤1 gene develop lethal immune disease with massive T cell proliferation, activation, and Th1 differentiation further demonstrated an essential role for TGF-␤1 in regulating T cell immunity. 26 Thus, in addition to the inhibitory effect of latent TGF-␤1 on NF.B-dependent renal inflammation as described in these studies, it is likely that the protective role of latent TGF-␤1 in crescentic GN may be attributable to the immunoregulatory role of TGF-␤1 in T regulatory and Th1 differentiation, which will require further investigation.
What are signaling mechanisms of TGF-␤1 leading to renal protection in mice overexpressing latent TGF-␤1? It is known that TGF-␤ activates its downstream mediators, Smad2 and Smad3, to exert its biologic effects such as renal fibrosis. 3, 27 At the same time, TGF-␤ also induces Smad7 expression which, in turn, inhibits Smad2/3 signaling and fibrosis. 3, 27 In Wt mice, severe renal fibrosis was associated with over activation of Smad2/3 caused by an increase in renal active TGF-␤1. This may also well explain the finding that mice overexpressing an active form of TGF-␤1 in the liver result in a ten-fold increase in bioactive TGF-␤1 in circulation and develop progressive liver and renal fibrosis. 9 In contrast, we report here that mice overexpressing latent TGF-␤1 were protected from renal fibrosis. This may be associated with a high level of renal Smad7, but a low level of activated Smad2/3 in response to a five-fold increase in plasma latent TGF-␤1 associated with a less than onefold increase in levels of plasma bioactive TGF-␤1 and a twofold increase in renal latent TGF-␤1 with a normal level of bioactive TGF-␤1 in the diseased kidney. These observations suggest that overexpression of Smad7 in response to higher levels of latent TGF-␤1 with normal or marginally elevated levels of active TGF-␤1 may be a critical mechanism of antirenal fibrosis in Tg mice. This is consistent with previous reports that overexpression of renal Smad7 blocks TGF-␤/ Smad2/3-mediated renal fibrosis in vitro and in obstructive and remnant kidney diseases. 28 -30 Beyond the anti-fibrotic effect, Smad7 is capable of inhibition of renal inflammation. Overexpression of Smad7 in T cells has been shown to prevent a mouse model of anti-GBM GN. 31 We have also shown that overexpression of renal Smad7 is capable of blocking renal inflammation by inhibiting NF.B/p65 activation via induction of IB␣ in vivo and in vitro. 10, 32 The study presented here added new information that overexpression of latent TGF-␤1 resulted in upregulation of renal Smad7, which leads to inhibition of both NF.B-dependent renal inflammation and Smad2/3-mediated renal fibrosis in anti-GBM GN. Thus, overexpression of Smad7 may be a central mechanism by which mice with overexpression of latent TGF-␤1 were protected from renal fibrosis and inflammation.
An interesting observation in this study is that although Tg mice were protected against renal inflammation, they developed inflammatory skin lesions. 33 The discrepancy between kidney and skin lesions may be associated with the local levels of latent and active TGF-␤1, which has been discussed previously. 10 However, it remains unclear as how increased latent TGF-␤1 in circulation and kidney tissues upregulates renal Smad7. Smad7 is induced by TGF-␤1 via a Smad2/3-dependent mechanism. 27 However, we found that renal Smad7, BASIC RESEARCH www.jasn.org which is high in the normal kidney, is reduced in the diseased kidney associated with over activation of TGF-␤/Smad2/3 signaling and renal fibrosis. 28, 29 This suggests that TGF-␤-induced Smad7 is regulated in a complex manner. It is possible that a persistent higher level of latent TGF-␤1 in both plasma and kidney tissues as seen in Tg mice may allow maintenance of a low significant level of active TGF-␤1 (a 0.6-fold increase compared with normal Wt mice), which may favor activation of Smad2/3 under the physiologic conditions, thereby inducing renal Smad7 expression without causing renal fibrosis. However, this was lost when Smad2/3 became overactivated in response to higher levels of active TGF-␤1, as seen in Wt mice in this and other diseased models. 9, 28, 29 It is also possible that upregulation of renal Smad7 may be post-transcriptionally regulated, as acetylation of Smad7 in response to TGF-␤ is able to protect it from Smurf-mediated ubiquitination and degradation. 34, 35 Nevertheless, although mechanisms whereby upregulation of renal Smad7 in mice with overexpression of latent TGF-␤1 remain largely unknown, results from this study implicate that latent TGF-␤1 may have therapeutic potential for renal inflammation and fibrosis.
CONCISE METHODS
Animal Model of Anti-GBM GN
K5.TGF-␤1
wt Tg mice were generated from ICR background mice as described previously. 33 Accelerated anti-GBM GN was induced in both TGF-␤1 Tg and Wt mice (20 g, aged 3 mo) following the established protocol. 36, 37 Groups of eight mice were euthanized on day 14. In addition, groups of six normal Wt and Tg mice were used as normal age-matched controls. Kidney tissues were collected for histology, immunohistochemistry, Western blot, and real-time PCR analyses. The Committee on the Use of Live Animals for Teaching and Research at the University of Hong Kong approved the experimental procedures.
Measurement of Proteinuria
All mice were housed in metabolic cages before and after induction of disease at days 0, 1, 7 and 14 for 16-h urinary protein excretion. Urinary protein excretion was determined using Coomasie Blue method. Plasma and urinary creatinine were determined by an ELISA kit as described previously. 29, 36 Measurement of TGF-␤1 and Mouse Immunoglobulins in Plasma TGF-␤1 levels in plasma and renal tissues including the active form, the LAP, and total TGF-␤1 were quantitatively analyzed by the human TGF-␤1 DuoSet ELISA development system (DY240) that has been shown to recognize mouse TGF-␤ (R&D System Inc., Minneapolis, MN) as described previously. 10, 38 Circulating levels of mouse immunoglobulins were measured by ELISA following the established protocol. 36 
Western Blot Analysis
Protein from kidney tissues was extracted with RIPA lysis buffer and Western blot analysis was performed as described previously. 10 After blocking nonspecific binding with 5% BSA, membranes were then incubated overnight at 4°C with the primary antibody against Smad7 (Santa Cruz Biotech Inc., Santa Cruz, CA), and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Chemicon Inc., Temecula, CA), followed by a horseradish peroxidase-conjugated secondary antibody. The signals were visualized by an enhanced chemiluminescence system (Amersham, Piscataway, NJ).
Real-Time PCR
Total kidney RNA was isolated using the RNeasy kit, according to the manufacturer's instructions (Qiagen Inc., Valencia, CA). The cDNA was synthesized and real-time PCR was run with the Opticon2 realtime PCR machine (Bio-Rad, Hercules, CA) by using IQ SYBR green supermix reagent (Bio-Rad, Herculus, CA) as described previously. 10 The primers used in this study, including mouse Smad7, IL-1␤, TNF-␣, collagen I and III, ␣-SMA, and GAPDH were described previously. 10, 39 The mouse MCP-1 primer used in this study was: forward 5Ј-CTTCTGGGCCTGCTGTTCA, reverse 5Ј-CCAGCCTACTCAT-TGGGATCA.
Histology and Immunohistochemistry
Changes in renal morphology were examined in methyl Carnoy'sfixed, paraffin-embedded tissue sections (4 m) stained with hematoxylin and eosin or periodic acid-Schiff (PAS) methods. Immunostaining was performed in paraffin sections using a microwavedbased antigen retrieval technique. 40 The antibodies used in this study included: rat anti-mouse monoclonal antibody to macrophages (F4/ 80) (Serotec, Ltd, Oxford, UK), rabbit polyclonal antibodies to CD3 Deposition of immune reactants within the kidney was assessed by direct immunofluorescence with FITC-conjugated polyclonal antibodies to sheep IgG, mouse IgG, and complement C3 as described previously. 37 Semiquantitation of sheep IgG, mouse IgG, and C3 deposition was determined in tissue sections using an antibody titration method. 35 Quantitative analyses of histology and immunostaining were carried on coded slides. Glomerular crescent formation and necrosis were scored by counting 50 glomeruli on PAS-stained section and expressed as percentage. The number of positive cells for CD3, F4/80, PCNA, p-Smad2/3 and NF.B/pp65 was counted in 20 consecutive glomeruli and expressed as cells/glomerular cross-section (gcs), whereas positive cells in the tubulointerstitium were counted under high-power fields (ϫ40) by means of a 0.0625-mm 2 graticule fitted in the eyepiece of the microscope, and expressed as cells per mm 2 .
Statistical Analyses
Data obtained from this study are expressed as the mean Ϯ SEM. Statistical analyses were performed using one-way ANOVA from GraphPad Prism 3.0 (GraphPad Software, Inc. San Diego, CA).
